Chinese english Germany Japanese Korea

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester Struktur
2826263-78-7
CAS-Nr.
2826263-78-7
Englisch Name:
Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester
Synonyma:
Methyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pentan-1-yl)cyclopropane-1-carboxylate;Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester
CBNumber:
CB712548326
Summenformel:
C16H25BO4
Molgewicht:
292.18
MOL-Datei:
2826263-78-7.mol
Request For Quotation

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester Eigenschaften

Siedepunkt:
317.9±42.0 °C(Predicted)
Dichte
1.13±0.1 g/cm3(Predicted)

Sicherheit

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Haohong Pharmaceutical Co., Ltd. 400-400-8210725 4008210725
 malulu@leyan.com China 40000 58
  • Cyclopropanecarboxylic acid, 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pent-1-yl]-, methyl ester
  • Methyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)bicyclo[1.1.1]pentan-1-yl)cyclopropane-1-carboxylate
  • 2826263-78-7
Copyright 2019 © ChemicalBook. All rights reserved